Newsletter | March 27, 2025

03.27.25 -- Is Double Programming Really Required For Validation?

SPONSOR

The CMO Summit 360°®, happening April 7-8 in Boston, is the largest gathering of biotech Chief Medical Officers across indications, modalities, company stages, professional experience levels and geographic locations. This is the conference to connect with peers and develop the skills needed to succeed as a biotech CMO.

FEATURED EDITORIAL

Is Double Programming Really Required For Validation?

Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

INDUSTRY INSIGHTS

Implementing eSource: A Guide For Operations And Technology Roles

By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.

Leveraging DHTs To Improve Data Collection And Analysis

How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?

How eConsent Delivers Value For Sponsors

Delve into the data substantiating experiences with electronic informed consent to better understand their positive impact on the outcomes of clinical trials.

The Digital Teammate: How AI Is Changing Clinical Research

AI in clinical research serves as a "digital colleague," enhancing workflows, accelerating data analysis, and empowering study teams with precision, and insightful solutions for better patient outcomes.

Mastering Scientific Communication Plans Within Medical Affairs

Join industry leaders from Anju and 9 Labs for a presentation on the pivotal role of Strategic Communication Plans (SCP) in medical affairs.

Data-Driven Physician Engagement For Ultra-Rare Diseases

How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?

The Transformative Role Of Digital Health Technologies

Digital health technologies are transforming clinical trials through decentralization, improved data, and patient-centric approaches, driving efficiency and accessibility.

Do We Still Need Patients In Tomorrow's Trials?

Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.